{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T03:13:37Z","timestamp":1785726817726,"version":"3.56.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00415-011-6077-y","type":"journal-article","created":{"date-parts":[[2011,5,11]],"date-time":"2011-05-11T04:23:29Z","timestamp":1305087809000},"page":"2097-2099","source":"Crossref","is-referenced-by-count":3,"title":["Reversible cardiac valve fibrosis secondary to treatment with high-dose cabergoline for Parkinson\u2019s disease"],"prefix":"10.1007","volume":"258","author":[{"given":"Johannes","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Neudert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Zwermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"N\u00e4bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"B\u00f6tzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"issue":"11","key":"6077_CR1","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1468-1331.2006.01547.x","volume":"13","author":"M Horstink","year":"2006","unstructured":"Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P et al (2006) Review of the therapeutic management of Parkinson\u2019s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson\u2019s disease. Eur J Neurol 13(11):1170\u20131185","journal-title":"Eur J Neurol"},{"issue":"7","key":"6077_CR2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/01.wnl.0000238508.68593.1d","volume":"67","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto M, Uesugi T, Nakayama T (2006) Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study. Neurology 67(7):1225\u20131229","journal-title":"Neurology"},{"issue":"9","key":"6077_CR3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S1474-4422(07)70218-1","volume":"6","author":"A Antonini","year":"2007","unstructured":"Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson\u2019s disease. Lancet Neurol 6(9):826\u2013829","journal-title":"Lancet Neurol"},{"issue":"12","key":"6077_CR4","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/mds.20329","volume":"19","author":"R Horowski","year":"2004","unstructured":"Horowski R, Jahnichen S, Pertz HH (2004) Fibrotic valvular heart disease is not related to chemical class but to biological function: 5-HT2B receptor activation plays crucial role. Mov Disord 19(12):1523\u20131524","journal-title":"Mov Disord"},{"issue":"9416","key":"6077_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","volume":"363","author":"G Camp Van","year":"2004","unstructured":"Van Camp G, Flamez A, Cosyns B, Goldstein J, Perdaens C, Schoors D (2004) Treatment of Parkinson\u2019s disease with pergolide and relation to restrictive valvular heart disease. Lancet 363(9416):1179\u20131183","journal-title":"Lancet"},{"issue":"11","key":"6077_CR6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00415-007-0592-x","volume":"254","author":"E Ruzicka","year":"2007","unstructured":"Ruzicka E, Linkova H, Penicka M, Ulmanova O, Novakova L, Roth J (2007) Low incidence of restrictive valvulopathy in patients with Parkinson\u2019s disease on moderate dose of pergolide. J Neurol 254(11):1575\u20131578","journal-title":"J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6077-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6077-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6077-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:13:09Z","timestamp":1559070789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6077-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["6077"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6077-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]}}}